Skip to main content
. 2020 Sep 21;2020:2036545. doi: 10.1155/2020/2036545

Table 5.

Distribution of SSc values, and prevalence of fQRS, according to the occurrence of secondary endpoints.

SSc values Presence of fQRS (74 pts)
Median 25/75 percentile p value Yes No p value
VT/VF (20 pts) 7.5 4–13 0.260 10 (50%) 10 (50%) 0.417
No VT/VF (158 pts) 6 4–10 64 (40.5%) 94 (59.5%)

HF hospitalization (34 pts) 6.5 4–13 0.432 15 (44.1%) 19 (55.9%) 0.738
No HF hospitalization (144) 6.5 4–10 59 (41%) 85 (59%)

Cardiac death (18 pts) 7.5 5–11 0.145 15 (53.6%) 13 (46.4%) 0.161
No cardiac death (160 pts) 6 4–10 59 (36.9%) 91 (56.9%)

All-cause death (28 pts) 7 4–11 0.377 9 (50%) 9 (50%) 0.444
No death (150 pts) 6 4–10 65 (40.6%) 95 (59.4%)

MACE (66 pts) 7 4–12 0.065 30 (45.4%) 36 (45.6%) 0.420
No MACE (112 pts) 6 3–9 44 (39.3%) 68 (60.7%)

Continuous variables are expressed as median and 25°/75° percentiles, and compared by the Mann–Whitney U test; categorical variables as number of patients (%) and compared by the χ2 test. SSc, Selvester score; fQRS, fragmented QRS; VT, ventricular tachycardia; VF, ventricular fibrillation; HF, heart failure; and MACE, major adverse cardiovascular event.